Point72 Hong Kong LTD Pmv Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $108,436 - $163,416	9,512 New	9,512 $113,000
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $56,245 - $89,136	-3,785 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$19.99 - $30.24 $75,662 - $114,458	3,785 New	3,785 $87,000
Q4 2020 Feb 16, 2021	SELL	$31.86 - $61.51 $200,431 - $386,959	-6,291 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $223,330 - $239,058	6,291 New	6,291 $223,000

41.7M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $64.8M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.